UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Nature medicine, 2021-10, Vol.27 (10), p.1752-1760

2021

Volltextzugriff (PDF)

HIV Patients’ Tracer for Clinical Assistance and Research during the COVID-19 Epidemic (INTERFACE): A Paradigm for Chronic Conditions

Information (Basel), 2022-02, Vol.13 (2), p.76

2022

Volltextzugriff (PDF)

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy : a multicohort analysis

AIDS (London), 2008-09, Vol.22 (14), p.1759-1767

2008

Volltextzugriff (PDF)

Clinical and Virological Monitoring During Treatment with Intrathecal Cytarabine in Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

Clinical infectious diseases, 1999-03, Vol.28 (3), p.624-628

1999

Volltextzugriff (PDF)

Impaired CD4 T-Cell Count Response to Combined Antiretroviral Therapy in Antiretroviral-Naive HIV-Infected Patients Presenting With Tuberculosis as AIDS-Defining Condition

Clinical infectious diseases, 2012-03, Vol.54 (6), p.853-861

2012

Volltextzugriff (PDF)

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma

AIDS (London), 2010-09, Vol.24 (15), p.2408-2412

2010

Volltextzugriff (PDF)

The Effect of Potent Antiretroviral Therapy and JC Virus Load in Cerebrospinal Fluid on Clinical Outcome of Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

The Journal of infectious diseases, 2000-10, Vol.182 (4), p.1077-1083

2000

Volltextzugriff (PDF)

Patient-reported nonadherence to HAART is related to protease inhibitor levels

Journal of acquired immune deficiency syndromes (1999), 2000-06, Vol.24 (2), p.123

2000

Volltextzugriff (PDF)

Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients

AIDS research and human retroviruses, 2006-05, Vol.22 (5), p.386

2006

Volltextzugriff (PDF)

Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis

Journal of neurovirology, 2007-08, Vol.13 (4), p.338-346

2007

Volltextzugriff (PDF)

Virologic correlates of adherence to antiretroviral medications and therapeutic failure

Journal of acquired immune deficiency syndromes (1999), 2002-12, Vol.31 Suppl 3, p.S118

2002

Volltextzugriff (PDF)

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics

Journal of acquired immune deficiency syndromes (1999), 2004-04, Vol.35 (4), p.359

2004

Volltextzugriff (PDF)

Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure

Journal of acquired immune deficiency syndromes (1999), 2007-08, Vol.45 (4), p.411

2007

Volltextzugriff (PDF)

Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy

Journal of acquired immune deficiency syndromes (1999), 2001-04, Vol.26 (4), p.326

2001

Volltextzugriff (PDF)

Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

Journal of neurovirology, 2005-04, Vol.11 (2), p.219-224

2005

Volltextzugriff (PDF)

Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma

Annals of neurology, 1999-02, Vol.45 (2), p.259-261

1999

Volltextzugriff (PDF)

Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey

Journal of acquired immune deficiency syndromes and human retrovirology, 1997-12, Vol.16 (5), p.350

1997

Volltextzugriff (PDF)

Changing disease patterns in focal brain lesion-causing disorders in AIDS

Journal of acquired immune deficiency syndromes and human retrovirology, 1998-08, Vol.18 (4), p.365

1998

Volltextzugriff (PDF)

Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/ hepatitis C virus co-infected patients

AIDS (London), 2004-07, Vol.18 (11), p.1602-1604

2004

Volltextzugriff (PDF)

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients. Commentary

AIDS (London), 2005, Vol.19 (15), p.1643-1694

2005

Volltextzugriff (PDF)

Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma

AIDS research and human retroviruses, 2002, Vol.18 (1), p.19-26

2002

Volltextzugriff (PDF)

Variable Prediction of Antiretroviral Treatment Outcome by Different Systems for Interpreting Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance

The Journal of infectious diseases, 2003-06, Vol.187 (12), p.1934-1943

2003

Volltextzugriff (PDF)

Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial

Journal of acquired immune deficiency syndromes (1999), 2001-05, Vol.27 (1), p.49

2001

Volltextzugriff (PDF)

Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent Membrane Protein 1

The American journal of pathology, 2002-07, Vol.161 (1), p.163-171

2002

Volltextzugriff (PDF)

Circulating levels and ex vivo production of β-chemokines, interferon γ, and interleukin 2 in advanced human immunodeficiency virus type 1 infection : The effect of protease inhibitor therapy

AIDS research and human retroviruses, 2000-06, Vol.16 (9), p.835-843

2000

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

ThemaViral Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Infectious Diseases
(26)
Biological And Medical Sciences
(25)
Medical Sciences
(25)
Human Viral Diseases
(24)
Humans
(24)
Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(22)
Female
(20)
Male
(20)
Adult
(19)
Immunology
(18)
Aids/hiv
(17)
Human Immunodeficiency Virus
(15)
Virology
(15)
Hiv Infections - Drug Therapy
(14)
Hiv
(13)
Microbiology
(10)
Anti-Hiv Agents - Therapeutic Use
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

HIV Patients’ Tracer for Clinical Assistance and Research during the COVID-19 Epidemic (INTERFACE): A Paradigm for Chronic Conditions

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy : a multicohort analysis

Clinical and Virological Monitoring During Treatment with Intrathecal Cytarabine in Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

Impaired CD4 T-Cell Count Response to Combined Antiretroviral Therapy in Antiretroviral-Naive HIV-Infected Patients Presenting With Tuberculosis as AIDS-Defining Condition

Detrimental clinical interaction between ritonavir-boosted protease inhibitors and vinblastine in HIV-infected patients with Hodgkin's lymphoma

The Effect of Potent Antiretroviral Therapy and JC Virus Load in Cerebrospinal Fluid on Clinical Outcome of Patients with AIDS-Associated Progressive Multifocal Leukoencephalopathy

Patient-reported nonadherence to HAART is related to protease inhibitor levels

Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients

Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis

Virologic correlates of adherence to antiretroviral medications and therapeutic failure

Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics

Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure

Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy

Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy

Epstein-Barr virus in monitoring the response to therapy of acquired immunodeficiency syndrome-related primary central nervous system lymphoma

Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey

Changing disease patterns in focal brain lesion-causing disorders in AIDS

Liver fibrosis stage predicts early treatment outcomes with peginterferon plus ribavirin in HIV/ hepatitis C virus co-infected patients

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients. Commentary

Characterization of Epstein-Barr virus genotype in AIDS-related non-Hodgkin's lymphoma

Variable Prediction of Antiretroviral Treatment Outcome by Different Systems for Interpreting Genotypic Human Immunodeficiency Virus Type 1 Drug Resistance

Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial

Expression of Cyclin-Dependent Kinase Inhibitor p27Kip1 in AIDS-Related Diffuse Large-Cell Lymphomas Is Associated with Epstein-Barr Virus-Encoded Latent Membrane Protein 1

Circulating levels and ex vivo production of β-chemokines, interferon γ, and interleukin 2 in advanced human immunodeficiency virus type 1 infection : The effect of protease inhibitor therapy

Aktive Filter

Suchergebnisse filtern